Literature DB >> 10103

An abnormal form of purine nucleoside phosphorylase in a family with a child with severe defective T-cell-and normal B-cell immunity.

L H van Heukelom, G E Staal, J W Stoop, B J Zegers.   

Abstract

1. Purine nucleoside phosphorylase and adenosine deaminase (ADA) were studied in normal red blood cells and lymphocytes and in the cells of a family with a child with a defective T-cell-and normal B-cell immunity. 2. In the propositus no purine nucleoside phosphorylase (NP) activity could be detected in her red cells and lymphocytes, while the ADA activity was somewhat increased. The NP activities of the father, mother and brother of the propositus are in the heterozygote range. The decreased activity of NP was not only found for the substrate inosine but also when guanosine or xanthosine were used as substrate. The mode of inheritance is autosomal recessive. 3. With starch gel electrophoresis no NP activity could be detected in the patient's haemolysate. The electrophoretic patterns of NP from the father, mother and brother of the patient seem to be the same as for normal NP with six bands of NP activity. 4. The nucleoside phosphorylases of the father, mother and brother of the patient were characterized by an increased KM for the substrate inosine, normal pH optimum and a decreased heat stability.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10103      PMCID: PMC8333443          DOI: 10.1016/0009-8981(76)90042-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  9 in total

Review 1.  Combined immunodeficiency and inborn errors of purine metabolism.

Authors:  H J Meuwissen; B Pollara
Journal:  Blut       Date:  1978-10-13

2.  Purine nucleoside phosphorylase deficiency. Measurement of variant protein in four families with enzyme-deficient members by an enzyme-linked immunosorbent assay.

Authors:  W R Osborne; C R Scott
Journal:  Am J Hum Genet       Date:  1980-11       Impact factor: 11.025

3.  Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes.

Authors:  G E Staal; J W Stoop; B J Zegers; L H Siegenbeek van Heukelom; M J van der Vlist; S K Wadman; D W Martin
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

4.  Purine nucleoside phosphorylase in lymphocytes of various mammalian species.

Authors:  M Borgers; F Thone
Journal:  Histochem J       Date:  1978-11

5.  Human purine nucleoside phosphorylase cDNA sequence and genomic clone characterization.

Authors:  S R Williams; J M Goddard; D W Martin
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

6.  Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency.

Authors:  M R Aust; L G Andrews; M J Barrett; C J Norby-Slycord; M L Markert
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

7.  Purine nucleoside phosphorylase deficiency. Evidence for molecular heterogeneity in two families with enzyme-deficient members.

Authors:  W R Osborne; S H Chen; E R Giblett; W D Biggar; A A Ammann; C R Scott
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

8.  Orotic aciduria in two unrelated patients with inherited deficiencies of purine nucleoside phosphorylase.

Authors:  A Cohen; G E Staal; A J Ammann; D W Martin
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

9.  Ecto-5'-nucleotidase activity in human T cell subsets. Decreased numbers of ecto-5'-nucleotidase positive cells from both OKT4+ and OKT8+ cells in patients with hypogammaglobulinemia.

Authors:  L F Thompson; A Saxon; R D O'Connor; R I Fox
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.